Furthermore, we determined that TrkA/CD44v3 complex formation is higher in PR-negative than PR-positive tumors, and a strong tendency (p = 0.0528) exists for the presence of the complex to correlate with triple-negative status in breast cancer and inversely correlate with the estrogen receptor (p = 0.0657). The gene discussed is NTRK1; the disease is breast carcinoma.